New Key Statistics Module, Z-Score and F-Score
WBO:BIO3 Key Ratios
Market Cap € M | 1,365.21 |
Enterprise Value € M | 1,860.82 |
P/E(ttm) | 8.54 |
PE Ratio without NRI | 8.54 |
Forward PE Ratio | 18.07 |
Price/Book | 3.06 |
Price/Sales | 2.04 |
Price/Free Cash Flow | 13.91 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.01 |
Revenue (TTM) € M | 809.00 |
EPS (TTM) € | 4.85 |
Beneish M-Score | -2.54 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 1,266.10 |
EV-to-EBIT | 8.12 |
EV-to-EBITDA | 8.12 |
PEG | -- |
Shares Outstanding M | 39.57 |
Net Margin (%) | 23.76 |
Operating Margin % | 25.50 |
Pre-tax Margin (%) | 23.77 |
Quick Ratio | 0.88 |
Current Ratio | 2.45 |
ROA % (ttm) | 14.14 |
ROE % (ttm) | 40.11 |
ROIC % (ttm) | 17.21 |
Dividend Yield % | 0.14 |
Altman Z-Score | 2.78 |
WBO:BIO3 Number of Guru Trades
WBO:BIO3 Volume of Guru Trades
Gurus Latest Trades with WBO:BIO3
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WBO:BIO3 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data